Alzheimer's Disease and Dementia
Featured Topics
Lead story
Other featured articles
-
Key Barriers for Clinical Trials for Alzheimer’s Disease
Alzheimer’s disease (AD) clinical trials are more complicated, costly, and slower than trials for other diseases. Addressing barriers would accelerate the approval of innovative therapies.
Posted in -
Research Spotlight: Alzheimer’s Disease
Schaeffer Center researchers are analyzing trends associated with a greying population, including AD prevalence and cost, and what these trends mean for society.
Posted in -
Prospects for Future Advances in Alzheimer’s Disease
This paper revisits expert predictions for future advances in Alzheimer’s disease (AD) made in 2001 and projects future breakthroughs over the next 20 years.
Posted in -
The Value of Delaying Alzheimer’s Disease Onset
Models show that the number of patients will more than double in 40 years, and costs associated with their care will nearly quintuple.
Posted in
About this section
Even small delays in the onset of Alzheimer's disease and dementia could have significant impacts for the patient, their family and caregivers, and the healthcare system more broadly. The Schaeffer Center's microsimulation models demonstrate there may be preventive measures we can take now to shape the nation's future health.
OUR EXPERTS ON ALZHEIMER'S DISEASE AND DEMENTIA PREVENTION
Our Work In Alzheimer's Disease and Dementia
-
FDA’s Approval of Aducanumab Paves the Way for ‘More Momentous’ Alzheimer’s Breakthroughs
New in STAT, Dana Goldman and Darius Lakdawalla discuss how the FDA’s recent approval of the first disease modifying therapy aducanumab against Alzheimer’s disease will pave the way for bigger breakthrough.
Categorized in -
Podcast: The Impact and Economics of Alzheimer’s
Julie Zissimopoulos recently spoke about her research using economic insights to better understand the impact of Alzheimer’s disease on individuals, families, caregivers, and society.
-
Information Session for Schaeffer Center Pilot Funding
Join us on Tuesday, January 12 to learn more about upcoming pilot funding opportunities through Schaeffer Center for Roybal Center for Behavioral Interventions in Aging, CeASES-ADRD and USC Alzheimer’s Disease Resource Center for Minority Aging Health Economics Research.
-
Health and Social Correlates of Dementia in Oldest‐Old Mexican‐Origin Populations
Substantial gaps in research remain across oldest‐old ethnic populations while the burden of dementia increases exponentially with age among Mexican and Mexican American older adults.
-
Applying for the 2021-2022 CeASES-ADRD Pilot Award
All application information must be submitted by the close of business on Friday, February 5, 2021.
-
Cognitive Assessment At Medicare’s Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans
The study provides new insights – the self-reports of survey respondents – into cognitive assessments at annual wellness visits, an area that has been somewhat hidden from view.
Categorized in